Work

Figure 5 from Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study

Year: 2025

Type: other

Abstract: GSEA of RNA-seq data of four Acetalax-sensitive PDX tumors vs. eight resistant, as compared with no drug controls. The Acetalax-sensitive PDXs were HBCx-209, HBCx-HBCx-12A, HBCx-204, and HBCx-158. The Acetalax-resistant PDXs were HBCx-39, HBCx-11, HBCx-4, HBCx-170, HBCx-185, HBCx-210, HBCx-217, and HBCx-172.

DOI: 10.1158/2767-9764.28512662

Authors: William C. Reinhold, Elisabetta Marangoni, Fathi Elloumi, Remi Montagne, Sudhir Varma, Yanghsin Wang, Keyvan Rezai, Ludivine Morriset, Ahmed Dahmani, Rania El Botty, Léa Huguet, Makito Mizunuma, Naoko Takebe, Samuel Huguet, Augustin Luna, Yves Pommier

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4408033839

Cites:

Cited by:

Related to: 10